Technical Analysis for PRTX - Protalex Inc

Grade Last Price % Change Price Change
grade F 0.0095 90.00% 0.0045
PRTX closed up 90.0 percent on Wednesday, August 21, 2019, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PRTX trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 90.00%
Wide Bands Range Expansion 90.00%
Down 3 Days in a Row Weakness 90.00%
Oversold Stochastic Weakness 90.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 21.79%

Older signals for PRTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Protalex, Inc. is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company's lead product candidate, PRTX-100, is a formulation of the Staphylococcal bacterial protein known as Protein A, which modifies aspects of the human immune system. PRTX-100 has the ability, at very low concentrations, to bind to human B-lymphocytes and macrophages and to modulate immune processes. The Company's pre-clinical studies demonstrated that low doses of PRTX-100 have potent therapeutic effects in certain models of immune-mediated inflammatory diseases. Both the PRTX-100-103 and the PRTX-100-104 studies demonstrated that PRTX-100 is safe and well tolerated at all dose levels.
Medicine RTT Medical Specialties Immunology Immune System Autoimmune Diseases Arthritis Rheumatoid Arthritis Autoimmunity Immune Thrombocytopenia Infliximab
Is PRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 3.0
52 Week Low 0.0002
Average Volume 8,669
200-Day Moving Average 0.2415
50-Day Moving Average 0.0524
20-Day Moving Average 0.0245
10-Day Moving Average 0.011
Average True Range 0.011
ADX 10.74
+DI 43.7785
-DI 27.8176
Chandelier Exit (Long, 3 ATRs ) 0.047
Chandelier Exit (Short, 3 ATRs ) 0.038
Upper Bollinger Band 0.0558
Lower Bollinger Band -0.0068
Percent B (%b) 0.26
BandWidth 255.510204
MACD Line -0.0144
MACD Signal Line -0.014
MACD Histogram -0.0004
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0095
Resistance 3 (R3) 0.0095 0.0095 0.0095
Resistance 2 (R2) 0.0095 0.0095 0.0095 0.0095
Resistance 1 (R1) 0.0095 0.0095 0.0095 0.0095 0.0095
Pivot Point 0.0095 0.0095 0.0095 0.0095 0.0095
Support 1 (S1) 0.0095 0.0095 0.0095 0.0095 0.0095
Support 2 (S2) 0.0095 0.0095 0.0095 0.0095
Support 3 (S3) 0.0095 0.0095 0.0095
Support 4 (S4) 0.0095